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Abstract
Background: According to WHO estimates, 35% of global measles deaths in 2011 occurred in India. In 2013, India
committed to a goal of measles elimination by 2020. Laboratory supported case based measles surveillance is an essential
component of measles elimination strategies. Results from a case-based measles surveillance system in Pune district
(November 2009 through December 2011) are reported here with wider implications for measles elimination efforts in India.
Methods: Standard protocols were followed for case identification, investigation and classification. Suspected measles cases
were confirmed through serology (IgM) or epidemiological linkage or clinical presentation. Data regarding age, sex,
vaccination status were collected and annualized incidence rates for measles and rubella cases calculated.
Results: Of the 1011 suspected measles cases reported to the surveillance system, 76% were confirmed measles, 6% were
confirmed rubella, and 17% were non-measles, non-rubella cases. Of the confirmed measles cases, 95% were less than 15
years of age. Annual measles incidence rate was more than 250 per million persons and nearly half were associated with
outbreaks. Thirty-nine per cent of the confirmed measles cases were vaccinated with one dose of measles vaccine (MCV1).
Conclusion: Surveillance demonstrated high measles incidence and frequent outbreaks in Pune where MCV1 coverage in
infants was above 90%. Results indicate that even high coverage with a single dose of measles vaccine was insufficient to
provide population protection and prevent measles outbreaks. An effective measles and rubella surveillance system
provides essential information to plan, implement and evaluate measles immunization strategies and monitor progress
towards measles elimination.
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Background
Recent estimates indicate that global measles mortality has
declined by 71% between 2000 and 2011 [1]. During the same
period measles deaths in India declined by a mere 36% and still
contribute to 35% of the global burden of measles deaths. India
reported a little above 29 000 measles cases in 2011, which was
certainly an underestimate. More recently, in September 2013,
eleven countries of WHO South-East Asia (SEA) region, which
includes India, have committed themselves to the goal of measles
elimination by 2020 [2].
Given India’s large burden of estimated measles cases and
deaths, successful measles control efforts in the country are
paramount to attaining regional and global measles elimination
goals. India’s existing strategy for measles control has the objective
of mortality reduction and not elimination and as such it depends
on measles outbreak surveillance rather than case based surveil-
lance [3]. As India develops strategies for measles elimination, a
case based measles surveillance system will likely form an integral
part of its operational plans in order to inform decisions regarding
appropriate strategy options, guide immunization activities and
evaluate progress towards elimination.
In December 2009, the Measles Aerosol Vaccine Project
(MAVP) of World Health Organization began a phase-II/III trial
for measles vaccine administered as an aerosol in Pune district
located in Maharashtra state [Clinical Trials Registry, India
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no.: CTRI/2009/091/000673 available at http://ctri.nic.in/
Clinicaltrials/login.php]. Study subjects were recruited from 94
villages spread over three contiguous Talukas or Blocks (1st sub-
district level administrative division in India) — Haveli, Khed and
Shirur of Pune. To systematically investigate and quantify the
intensity of measles virus transmission in these three blocks of Pune
included in the trial, it was deemed necessary to set up a case based
surveillance system that would meet international performance
standards and would run concurrently but independently of the
trial. The National Polio Surveillance Project of WHO-India
Country Office (WHO-NPSP) provided technical assistance to
Government of Maharashtra to establish a case-based measles
surveillance system in the MAVP Blocks (Unpublished document:
WHO-NPSP Project Proposal for case based measles surveillance
in MAVP Blocks of Pune). Concurrence from Government of
India and Maharashtra state government was obtained to design
and establish such a surveillance system. Apart from the
immediate needs of the aerosol vaccine project in 2009, we
believed that setting up this case based measles surveillance system
in Pune would also serve as a model for scaling up later, as India
takes on more aggressive measles control goals in future.
India had introduced one dose of measles vaccine between 9
and 12 months of age in its infant immunization programme in
1985. The latest evaluated coverage estimate for first dose of
measles containing vaccine (MCV1) among infants in India was
74% [4]. Evaluated MCV1 coverage in Maharashtra state in India
was 85% in 2007–08 and 91% in 2009. For Pune district, MCV1
coverage was 94% in 2007–2008 [5].
From 2010, India introduced a second dose of measles-
containing vaccine (MCV2) through catch-up campaigns targeting
children 9 months to 10 years of age in 14 states (which had
MCV1 coverage below 80%) and through routine immunization
programme for 16–24 month old children in 21 remaining states
(with MCV1 coverage at or above 80%) including Maharashtra
[6]. However, Maharashtra state had not introduced MCV2 in
routine immunization until July 2011. In absence of reliable
laboratory supported surveillance data it would be difficult to
assess the impact of the catch-up campaigns (14 states) and the
need for additional strategic interventions in the 21 states without
such campaigns.
This paper describes the epidemiology of measles in three
MAVP blocks of Pune for the period November 2009 through
December 2011. Surveillance system performance is assessed
against WHO internationally accepted indicators. Incidence rates
and burden of measles and policy implications for measles control
and elimination strategies for India are discussed. Design issues
that were critical for the success of this case based surveillance
system have been elaborated. We also discuss below why this
model of case based measles surveillance can be taken as an
example of legacy planning envisaged in the polio endgame
strategic plan [7].
Methods
Population and area under measles surveillance
Figure 1 shows the area under surveillance in the three
contiguous blocks, Haveli, Khed and Shirur of Pune district with
a population of 1.37 million. These blocks comprised of 467
villages including the 94 villages from which subjects for the
measles aerosol vaccine trial were recruited.
Establishment of case based measles surveillance
Measles case-based surveillance was built on the platform of
pre-existing network of reporting sites for Acute Flaccid Paralysis
(AFP) surveillance for polio in Pune. In 2010, Pune district had
451 AFP reporting sites in the polio surveillance network. The vast
majority of these reporting sites (85%) were private health care
facilities. All the AFP reporting sites and some additional clinical
care-givers were included in the network for measles surveillance
and were required to submit AFP plus suspected measles case
reports following a standard reporting protocol. Government and
WHO staff conducted periodic surveillance workshops to sensitize
and train clinical and other categories of personnel at the network
reporting sites.
Case definitions and case classification [8,9]
A suspected measles case was defined as any person in whom a
clinician suspected measles infection or any person with fever and
maculo-papular rash with cough or coryza (running nose) or
conjunctivitis (red eyes).
Based on laboratory and/or epidemiological criteria as
described below, a suspected measles case was classified into one
of the following categories
a) Laboratory confirmed measles or rubella case if
the person’s serum sample tested positive for either measles
or rubella IgM antibody;
b) Epidemiologically confirmed measles or rubella
case if the person’s serum could not be tested in a
laboratory for measles or rubella IgM (or returned
equivocal results) but the case was related geographically
and temporally (dates of rash onset within 21 days of each
other) to another confirmed measles or rubella case (either
laboratory-confirmed or epidemiologically confirmed);
c) Clinically confirmed measles case if the person’s
serum was could not be tested in a laboratory (or returned
equivocal results) and the case was also not epidemiolog-
ically linked to any other confirmed measles or rubella
case;
d) Discarded case if the serum sample tested negative for
both measles and rubella IgM or if no serum sample was
tested but the case was epidemiologically linked to an
outbreak that was negative for both measles and rubella.
For outbreak classification, please see below.
In this report, laboratory, epidemiologically or clinically
confirmed cases of measles have been collectively referred to as
‘confirmed measles cases’ and laboratory or epidemiologically
confirmed rubella cases of rubella as ‘confirmed rubella cases’.
A measles death was defined as a death which occurred within
30 days of onset of rash in a confirmed measles case [10].
Case reporting and investigation
For every suspected case of measles of any age resident in an
MAVP block, a case investigation form (CIF) was completed and a
blood sample was collected for serologic confirmation (either at the
reporting site or at the home of the case).
All suspected cases were offered appropriate clinical care
including therapeutic doses of vitamin A as per Govt. of India
guidelines [11].
Each suspected measles case reported from a reporting site and
resident in an MAVP block served to trigger a community search
for additional suspected measles cases by public health staff.
Additional cases detected were also investigated as described
above or as described below if an outbreak was identified.
All suspected measles cases from MAVP blocks were followed
up to ascertain their vital status (alive or dead) up to 30 days after
onset of rash. Health workers visited home of case (or clinic if
Case Based Measles Surveillance in Pune, India
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admitted) between 30 and 40 days after rash onset or earlier if
death was reported before 30 days.
Outbreak investigation
An outbreak was defined as a cluster of two or more suspected
measles cases in a village in a week or if there was a continuous
occurrence of cases every week over a 3–4 week period.
Identification of a suspected outbreak prompted active searches
in the community to identify additional cases by visiting all houses,
supplementary nutrition centres for children, and schools in the
village to detect more suspected measles cases of any age. Regular
visits by District Health staff and WHO staff continued until there
was a continuous period of three weeks during which no further
cases were reported or the lab results showed that the outbreak
was not due to measles [12].
Table 1 shows the protocol followed to classify outbreaks. When
an outbreak was classified as measles or rubella outbreak based on
laboratory results as per this protocol, the cases from that outbreak
from whom blood samples had not been collected (see below for
blood sample collection protocol) were classified as epidemiolog-
ically confirmed measles or rubella cases. If the outbreak was
classified as a ‘‘mixed outbreak’’, such cases were considered epi-
linked to a mixed outbreak without ascribing the aetiology of the
rash to either measles or rubella.
Laboratory sample collection and case confirmation
Blood samples were collected through venepuncture from every
suspected measles case that was reported as a sporadic case in any
of the MAVP blocks. The system aimed at collecting one serum
sample from every sporadic case within 28 days from onset of rash.
In the event of a suspected measles outbreak, blood samples
were collected from the initial cases of an outbreak until at least 5
samples had been collected or at least 2 samples from that
outbreak tested positive for either measles or rubella. The National
Institute of Virology (NIV), Pune tested blood samples for measles
immunoglobulin-M (IgM) through EIA with Enzygnost Anti-
Measles-Virus/IgM as per WHO protocol. Samples testing
negative for measles were tested for rubella IgM [13]. Measles
laboratory of NIV Pune was independently accredited by WHO.
Data compilation and sharing
Epidemiological data from surveillance and lab results from
NIV laboratory in Pune were linked through a unique identifier
assigned by the District Immunization Officer (DIO), Pune and
WHO Pune unit of the WHO National Polio Surveillance Project
(WHO-NPSP). WHO-NPSP central unit circulated summary
tables and charts to relevant stakeholders monthly.
Figure 1. Pune district showing blocks under case based measles surveillance.
doi:10.1371/journal.pone.0108786.g001
Table 1. Outbreak classification protocol.
Laboratory results of samples collected from an outbreak Classification of Outbreak Classification of cases in outbreak
$2 measles positive and ,2 rubella positive Measles Epidemiologically confirmed measles
$2 rubella positive and ,2 measles positive Rubella Epidemiologically confirmed rubella
$2 measles positive and$2 rubella positive Mixed Epidemiologically linked to mixed outbreak
,2 measles positive or ,2 rubella positive Discarded (negative measles and rubella) Discarded
doi:10.1371/journal.pone.0108786.t001
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If an outbreak or a suspected measles case was reported from
any of the villages from where subjects were recruited for the
measles aerosol vaccine trial, DIO, Pune and/or WHO Pune unit
immediately informed the local coordinator of the MAVP trial
area.
Statistical methods
Incidence rates for suspected measles, confirmed measles,
confirmed rubella and discarded cases were calculated per 100
000 person-years. Case fatality ratio (CFR %) for confirmed
measles cases was calculated as the ratio of measles deaths to the
number of confirmed measles cases, expressed as a percentage.
Performance indicators for measles surveillance were calculated
as recommended by WHO [8,14]. Timeliness and completeness of
reports of suspected measles cases from all the reporting units of
Pune district were calculated on a weekly basis and were the same
as reported to the AFP surveillance system.
The Kruskal-Wallis H test (One Way Analysis of Variance) was
applied to compare the difference between medians and the
Cornfield 95% confidence limits for odds ratio. Epi Info for
Windows version 3.5.3 released January 26, 2011 was used for
analysis.
Ethics statement
The case based measles surveillance system in Pune was set up
as part of public health disease surveillance of Govt. of
Maharashtra and as such explicit review by an ethics committee
was deemed unnecessary. Public health surveillance being a state
issue, permission was sought and obtained from Additional
Director of Health Services Govt. of Maharashtra before initiating
surveillance. Govt. of India guidelines for measles surveillance
were followed or adapted for all surveillance activities including
blood sample collection and clinical care of suspected measles
cases [11]. During outbreak investigations, verbal permission was
obtained from suspected measles cases and/or their caretakers
before collecting blood samples as per standard public health
surveillance practice. If the case was admitted to a clinic or
hospital, the surveillance team also obtained permission from the
attending clinician to draw a blood sample.
Results
The descriptive epidemiology of the measles cases identified
from surveillance week 45 of 2009 (starting 1 November 2009)
until week 52 of 2011 (ending 1 January 2012) is presented below
(Table 2). In addition, performance of the surveillance system has
also been assessed against global standards.
Summary case counts by classification
In total, 1011 suspected measles cases were reported through
the surveillance system. Of these, 169 (17%) were laboratory
negative for both measles and rubella and discarded and 772
(76%) were classified as confirmed measles cases. Of confirmed
measles cases, 509 were serum IgM positive, 228 were epidemi-
ologically-linked in time and space to a lab confirmed or an
epidemiologically confirmed measles case and 35 were confirmed
by meeting the clinical case definition only. An additional 58 cases
(6%) were confirmed rubella. Twelve cases (1%) were epidemio-
logically linked to an outbreak of both measles and rubella.
Measles outbreaks
Frequent measles outbreaks characterised measles transmission
in Pune. The surveillance system detected 21 suspected measles
outbreaks of which 20 were subsequently laboratory confirmed as
measles outbreaks (Table 3). One outbreak in 2011 was classified
as a mixed outbreak of both measles and rubella cases (29 cases).
Overall, 47% (362/772) of the confirmed measles cases occurred
as part of measles outbreak and the rest were sporadic measles
cases that did not occur in an outbreak setting.
Measles incidence and seasonal variation
During the 113-week period under observation, confirmed
measles cases occurred in 81% (91/113) of the weeks. Figure 2
shows persistent and regular cycles of measles transmission. Mean
weekly incidence of confirmed measles cases was seven. However,
measles incidence showed pronounced seasonal variation with the
mean weekly incidence increasing to 20 cases for a 17-week period
(week 44 of 2010 - week 8 of 2011) from November 2010 through
February 2011. In Pune, these are the winter months when the
average minimum monthly temperature remains at or below
15uCelsius [15]. For the two full calendar year periods (2010 and
2011) under surveillance, annual incidence rate of confirmed
measles cases was greater than 250 per million persons.
Age and sex distribution of cases by classification
Forty-five per cent of (349/772) of confirmed measles and 52%
(30/58) of confirmed rubella cases were female. Table 4 shows the
age distribution of confirmed measles, rubella and discarded cases.
Of the 772 confirmed measles cases, only 4% occurred in children
younger than 9 months of age (the recommended age of
vaccination) and about 10% of cases occurred in infants. Most
cases occurred in children 1–9 years of age (68%) while another
16% occurred before reaching 15 years of age and only 6%
occurred in persons older than 15 years of age. In contrast, there
were no confirmed rubella cases in infants. Of the 58 confirmed
rubella cases, 72% were between 1 and 10 years and another 22%
occurred before reaching 15 years of age. However, 6% of
confirmed rubella cases occurred in persons older than 15 years
demonstrating susceptibility to rubella during reproductive years.
Compared to rubella, measles virus infected earlier in life (,10
year old) and even in infancy, while some residual susceptibility to
both viruses remained beyond 15 years of age.
The median age, inter-quartile range and the minimum and
maximum age in months for confirmed measles cases (Median: 70;
inter-quartile range: 36 to 111), for confirmed rubella cases (M: 95;
IQR: 62 to 132) and for discarded cases (M: 47; IQR: 15 to 95) are
shown in Figure 3. The differences between the median ages were
statistically significant (Kruskal Wallis H= 28.429 at 2 degrees of
freedom, p= 0.000001).
Vaccination status of cases by classification
Overall 43% (437/1011) of the suspected measles cases reported
vaccination with at least one dose of measles containing vaccine
(MCV). Of the 437 cases who had a history of vaccination with
MCV, only 98 (22%) had supporting documents (vaccination card,
clinic prescription or vaccination register) in addition to historical
recall, while the rest had no such supporting documents.
Of the 772 confirmed measles cases, 298 (39%) reported
vaccination with at least one dose of MCV; of the 227 non-measles
cases (confirmed rubella and discarded), 135 (59%) were
vaccinated (Table 5). Only 34% of the confirmed measles cases
aged 9–11 months had a history of measles vaccination compared
to 68% of the discarded cases in the same age group. Similarly
only 39% of the confirmed measles cases 1–4 years of age had
history of measles vaccination compared to 67% of the discarded
cases in the same age group.
Case Based Measles Surveillance in Pune, India
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The odds ratio for vaccination with an MCV between a
confirmed measles case and a non-measles case was 0.43
(Cornfield 95% confidence limits for odds ratio: 0.31 to 0.59).
Case Fatality Ratio (CFR)
Of the 1011 suspected measles cases, 986 (98%) were followed
up 30 days from onset of rash to ascertain vital status. Two of the
1101 cases died within 30 days of rash onset. Both were confirmed
measles cases. The observed CFR in confirmed measles cases was
0.26% (2/772) and the 95% confidence interval for CFR was
0.00%–0.62%.
Surveillance performance indicators
The measles surveillance system in Pune met globally recom-
mended performance indicators for case based measles surveil-
lance [8,9].
Every week more than 80% of 451 reporting units submitted
complete and timely reports (Table 6). Except for the first few
weeks after start-up in 2009, the surveillance system consistently
achieved a reporting rate above 2 per 100 000 persons for
discarded cases and 70% of the suspected measles cases were
investigated within 48 hours of notification. Over 80% of the
suspected measles cases not linked to an outbreak had an adequate
blood sample taken.
Discussion
To our knowledge this is the first report from an active case
based laboratory supported measles surveillance system in India.
Earlier reports in India were mostly from special studies, outbreak
investigations or from passive reporting [16,17].
The World Health Assembly (WHA) in 2010 declared interim
milestones towards measles elimination to be achieved by 2015
[18]. One of the three milestones is to reduce annual measles
incidence to 5 per million persons in presence of adequate
surveillance. Our data documents endemic measles transmission in
Pune despite achieving evaluated coverage greater than 90% with
one dose of MCV. For both 2010 and 2011, the annual measles
incidence observed in Pune was more than 50 times (,270 per
million persons) above the interim targets set by WHA.
Reported measles incidence rate for India in 2011 was 24 per
million persons [1]. Given that the national MCV1 coverage for
India was 74% in 2009, lower than that evaluated for Pune (94%),
this likely underestimates the true incidence of measles in India
[4,5].
Simons et al. note the lack of reliable case based measles
surveillance data as a constraint in deriving realistic modelled
estimates of incident measles cases and deaths in India. Their
model estimated 65 500 (95% CI: 53 600–78 800) measles deaths
in India in 2010 [19]. Another retrospective sample survey of
cause-specific child mortality through verbal autopsies estimated
92 000 (99% CI: 79 000–104 000) measles deaths in India in 2005
[20]. A recent review of community based studies in India
determined median case fatality ratio (CFR) for measles at 1.63%
(IQR: 0%–5%) [21]. However, reported measles cases and deaths
are usually much lower, 48 181 cases and 188 deaths in 2008 [22].
Owing to paucity of reliable laboratory confirmed surveillance
data, estimates of measles cases and deaths for India are thus
affected by large levels of uncertainty. By providing additional
Table 2. Suspected measles cases by classification and incidence rates per 100 000 persons.
2009a 2010 2011
Number Incidence Rateb Number Incidence Rate Numberc Incidence Rate
Suspected measles 21 9.21 474 34.53 516 36.76
Confirmed measles (Laboratory,
epidemiologically or clinically confirmed)
17 7.46 376 27.39 379 27.00
Confirmed rubella (Laboratory or
Epidemiologically confirmed)
1 0.44 18 1.31 39 2.78
Discarded 3 1.32 80 5.83 86 6.13
a: 2009: From week 45; 2010 and 2011: entire year.
b: Annualized Incidence rate per 100,000 persons per year;
c: 12 cases were epi-linked to a mixed outbreak of measles and rubella.
doi:10.1371/journal.pone.0108786.t002
Table 3. Suspected measles outbreaks with classification.
2009a 2010 2011
Median no. of
cases (IQRb)
Median Duration in
days (IQR)
No. of Outbreaks
(cases)
No. of Outbreaks
(cases)
No. of Outbreaks
(cases)
Suspected measles
outbreaks
1 (7) 15 (267) 5 (117) 18 (8–26) 40 (22–68)
Confirmed measles
outbreaks
1 (7) 15 (267) 4 (88) 17 (8–23) 39 (22–64)
a: 2009: From week 45; 2010 & 2011: entire year.
b: IQR: Inter-quartile range.
doi:10.1371/journal.pone.0108786.t003
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population based estimates of confirmed measles incidence, our
data will possibly contribute to more robust and accurate estimates
of measles diseases burden in India.
In September 2013 India became a party to the WHO South
East Asia Regional declaration for measles elimination by 2020
[2]. However, India’s measles control programme is still focused
on measles mortality reduction rather than measles elimination
[3]. As India starts implementing its measles elimination
programme, a sensitive case based surveillance system will be
essential to guide immunization activities and monitor progress
towards the goal of elimination.
As of 2013, 11 states of India maintain laboratory supported
measles outbreak surveillance system with technical assistance
from WHO-NPSP. However, there is no national system for
laboratory supported case based measles surveillance. As India has
just completed the first round of measles catch-up campaigns in
2013, targeting 134 million children in 14 of its 35 states,
transitioning to laboratory supported case based measles surveil-
lance system will be necessary to substantiate the impact of the
intervention in these states [23]. To guide future measles control
and/or elimination strategies it would also be necessary to set up
case based measles surveillance systems in all other states of India.
At the time of this report, Pune district had not introduced a
second dose of MCV in its immunization program. Despite high
coverage (.90%) achieved with a single dose of measles vaccine
through routine immunization, endemic measles transmission with
periodic measles outbreaks continued to occur with nearly half of
confirmed measles cases associated with outbreaks. These findings
demonstrate that high level of vaccination coverage with one dose
of measles vaccine is insufficient to reach threshold levels of herd
protection required to interrupt measles transmission. This locally
derived empirical evidence provides additional support to current
Figure 2. Suspected measles cases by week of onset and final classification: 2009–2011.
doi:10.1371/journal.pone.0108786.g002
Table 4. Age distribution of confirmed measles, rubella and discarded cases, 2009–2011a.
Confirmed measles cases (%) Confirmed rubella cases (%) Discarded cases (%)
,9 months 32 (04) 0 (00) 15 (09)
9–11 months 44 (06) 0 (00) 19 (11)
1–4 years 265 (34) 13 (22) 66 (39)
5–9 years 264 (34) 29 (50) 43 (25)
10–14 years 125 (16) 13 (22) 20 (12)
.= 15 years 42 (06) 3 (06) 6 (04)
Total 772 (100) 58 (100) 169 (100)
a: Confirmed measles: Laboratory, epidemiologically or clinically confirmed measles cases; Confirmed rubella: Laboratory or epidemiologically confirmed rubella cases;
Discarded: Negative laboratory results for measles or rubella.
doi:10.1371/journal.pone.0108786.t004
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Government of India policy and WHO guidance for the need to
sustain high coverage with two doses of MCV for sustained
measles control [24]. Experience from several countries provide
corroborative evidence that high coverage with two doses of
measles vaccine is needed to sustain measles control and interrupt
transmission [25].
We also explored whether lowered effectiveness of one dose of
measles vaccine under field conditions could be the cause of
continued measles transmission and outbreaks in Pune. In our
data, 39% of the confirmed measles cases in the 1–4 year age
group were vaccinated. Applying the Orenstein curves and
equations to our observed data of 39% of cases vaccinated
(PCV) and 94% of population vaccinated (PPV) with MCV1,
estimated measles vaccine effectiveness is 96% [26]. This is well
within the range of estimated measles vaccine efficacy of 92%
(IQR: 84%–96%) at 9 months and 99% (IQR: 93–100%) at 11
months of age [27].
In Pune district, 78% of measles disease burden is borne by
children under 10 years and 95% of cases occur by 15 years of age.
Data from measles outbreak surveillance in other states of India
with MCV1 coverage equal or greater than 85% show a similar
pattern. In Tamil Nadu and Kerala, 80% and 71% of cases
respectively, occurred in children below 10 years of age in 2010
[28].
This has important policy implications. Between 2010 and
2013, India has implemented large scale measles catch-up
campaigns to vaccinate children between 9 months and 10 years
of age in 14 (out of 35) states with MCV1 coverage less than 80%
[23]. For the 21 remaining states (including Maharashtra) with
relatively higher MCV1 coverage, which have not undertaken
catch-up campaigns so far, the immunization programme will also
need to take into account measles disease burden and susceptibility
in older age cohorts (beyond 10 years) to reach the WHA
recommended interim goal of measles incidence of five per million
persons.
Figure 3. Confirmed measles, confirmed rubella and discarded cases: Box and whiskers plot for median, inter-quartile range,
minimum and maximum ages (months).
doi:10.1371/journal.pone.0108786.g003
Table 5. Number and proportion vaccinated a with measles containing vaccine by age-group and case classification b 2009–2011.
Confirmed measles cases Confirmed rubella cases Discarded cases
Number Proportion vaccinated Number Proportion vaccinated Number Proportion vaccinated
,9 months 32 6% 0 - 15 0%
9–11 months 44 34% 0 - 19 68%
1–4 years 265 39% 13 100% 66 67%
5–9 years 264 44% 29 76% 43 63%
10–14 years 125 41% 13 46% 20 40%
.= 15 years 42 26% 3 33% 6 17%
Total 772 39% 58 72% 169 55%
a: Vaccinated with at least 1 dose of measles containing vaccine.
b: Confirmed measles: Laboratory, epidemiologically or clinically confirmed; Confirmed rubella: Laboratory or epidemiologically confirmed; Discarded: Negative
laboratory results for measles or rubella.
doi:10.1371/journal.pone.0108786.t005
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Several limitations to our data should be noted. The reporting
network was geographically restricted to the district of Pune.
Measles cases (from the three MAVP blocks) that sought clinical
care at sites outside Pune district might well have been missed. In
India, as in other countries, the number of measles cases and
associated deaths may be underreported as measles cases may not
seek treatment at medical care facilities or cases are not reported
through the surveillance systems [29,30]. Except when doing an
outbreak investigation, we did not routinely canvass households for
suspected measles cases and might thus have missed some cases.
On the other hand, including clinical care providers within Pune,
from both public and private sectors (85% of reporting sites) in our
surveillance network ensured that cases attending either type of
health facility in the district were reported to the surveillance
system.
Case-based measles surveillance achieved most of the globally
recommended cardinal indicators of measles surveillance perfor-
mance (Table 6) including Incidence of discarded cases higher
than 2 per 100,000 persons and more than 80% suspected measles
cases with an adequate serum sample [8]. While it is believed that
the effectiveness and sensitivity of measles case-based surveillance
in Pune benefited from its link with highly sensitive polio AFP
surveillance, it cannot be assumed that all cases were detected.
Unfortunately, we did not test the sensitivity of the surveillance
system through a capture-recapture of cases or other methods and
are therefore unable to compare the epidemiological characteris-
tics (e.g. age, vaccination status etc.) of suspected cases missed by
the reporting system vs. those that were reported. The surveillance
system made follow-up visits to ascertain vital status up to 30 days
after onset of rash but did not systematically record all
complications occurring between onset and the follow-up visit.
In summary, the Pune case based measles surveillance system
was built on the pre-existing sensitive and robust system of AFP
surveillance for polio. Close coordination between Govt. staff and
Surveillance Officers of WHO-NPSP, periodic sensitization
workshops conducted for clinicians and public health staff, and
active search for suspected measles cases in health facilities and in
the community during outbreaks were critical elements in the
success of the surveillance system. Operationally, this was similar
to the surveillance system in place since the early 1990’s in the
Region of the Americas for measles surveillance in an elimination
setting [31,32].
This surveillance system was a tangible example of how polio
resources can be leveraged to support other vaccine preventable
disease control activities. WHO-NPSP has a country-wide network
of Surveillance Medical Officers supporting Government of India
and state governments in polio and measles outbreak surveillance.
The experience of establishing and supporting this surveillance
system in Pune with the direct involvement and collaboration
between Government staff and the WHO-NPSP polio surveillance
network can be replicated relatively easily in other states of India
to establish measles case based surveillance to monitor progress
towards measles elimination and inform immunization policy.
Globally, opportunities should also be explored to transition the
existing polio eradication infrastructure and trained human
resources to support broader immunization strengthening activi-
ties including integrated surveillance systems for measles and other
vaccine preventable diseases. This is a concrete example
demonstrating the feasibility of legacy planning objective of the
2013–2018 Polio Endgame Strategic Plan [7].
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Table 6. Performance indicators for case based measles surveillance Pune, 2009–2011.
2009 2010 2011
Number and completeness (%) of weekly reportinga (4850/5486) 88% (4559/5517) 83% (4895/5587) 88%
Number and timeliness (%) of weekly reportinga (4850/5486) 88% (4559/5517) 83% (4895/5587) 88%
Incidence of discarded cases per 100,000 persons in 3 MAVP blocksb,c 1.3 5.8 6.1
Number and proportion (%) of suspected measles cases with an adequate
sampled
(14/17) 82% (278/295) 94% (443/459) 97%
Number and proportion (%) of suspected measles cases investigated within
48 hours of notificatione
(21/21) 100% (390/474) 82% (362/516) 70%
a: For the entire district of Pune;
b: For year 2009, indicator calculated as an annualized rate from week 45;
c: Target$2 per 100,000 persons;
d: Target$80% [Cases which were epidemiologically linked to an outbreak of measles, rubella or another infectious disease or to an outbreak of unknown aetiology
excluded from denominator];
e: Target$80%.
doi:10.1371/journal.pone.0108786.t006
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